Organon & Co (OGN)
18.54
+0.12
(+0.68%)
USD |
NYSE |
Apr 26, 16:00
18.54
0.00 (0.00%)
After-Hours: 20:00
Organon Revenue (TTM): 6.263B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.263B |
| September 30, 2023 | 6.15B |
| June 30, 2023 | 6.168B |
| March 31, 2023 | 6.145B |
| December 31, 2022 | 6.174B |
| September 30, 2022 | 6.292B |
| June 30, 2022 | 6.355B |
| Date | Value |
|---|---|
| March 31, 2022 | 6.365B |
| December 31, 2021 | 6.304B |
| September 30, 2021 | 6.314B |
| June 30, 2021 | 6.327B |
| March 31, 2021 | 6.258B |
| December 31, 2020 | 6.532B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.145B
Minimum
Mar 2023
6.532B
Maximum
Dec 2020
6.281B
Average
6.292B
Median
Sep 2022
Revenue (TTM) Benchmarks
| Merck & Co Inc | 60.11B |
| Alnylam Pharmaceuticals Inc | 1.828B |
| Amgen Inc | 28.19B |
| Biogen Inc | 9.663B |
| Pacira BioSciences Inc | 674.98M |